447 related articles for article (PubMed ID: 16006135)
1. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.
Perrin V; Régulier E; Abbas-Terki T; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Mol Ther; 2007 May; 15(5):903-11. PubMed ID: 17375066
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
[TBL] [Abstract][Full Text] [Related]
5. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum.
Régulier E; Trottier Y; Perrin V; Aebischer P; Déglon N
Hum Mol Genet; 2003 Nov; 12(21):2827-36. PubMed ID: 12952868
[TBL] [Abstract][Full Text] [Related]
6. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.
Miller J; Arrasate M; Shaby BA; Mitra S; Masliah E; Finkbeiner S
J Neurosci; 2010 Aug; 30(31):10541-50. PubMed ID: 20685997
[TBL] [Abstract][Full Text] [Related]
7. High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes.
Wang L; Lin F; Wu J; Qin Z
Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):325-34. PubMed ID: 19352548
[TBL] [Abstract][Full Text] [Related]
8. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
[TBL] [Abstract][Full Text] [Related]
9. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.
Li H; Li SH; Yu ZX; Shelbourne P; Li XJ
J Neurosci; 2001 Nov; 21(21):8473-81. PubMed ID: 11606636
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.
Gabery S; Sajjad MU; Hult S; Soylu R; Kirik D; Petersén Å
Eur J Neurosci; 2012 Sep; 36(6):2789-800. PubMed ID: 22731249
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
Benchoua A; Trioulier Y; Zala D; Gaillard MC; Lefort N; Dufour N; Saudou F; Elalouf JM; Hirsch E; Hantraye P; Déglon N; Brouillet E
Mol Biol Cell; 2006 Apr; 17(4):1652-63. PubMed ID: 16452635
[TBL] [Abstract][Full Text] [Related]
12. Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice.
Zala D; Bensadoun JC; Pereira de Almeida L; Leavitt BR; Gutekunst CA; Aebischer P; Hayden MR; Déglon N
Exp Neurol; 2004 Jan; 185(1):26-35. PubMed ID: 14697316
[TBL] [Abstract][Full Text] [Related]
13. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum.
Ellison SM; Trabalza A; Tisato V; Pazarentzos E; Lee S; Papadaki V; Goniotaki D; Morgan S; Mirzaei N; Mazarakis ND
Mol Ther; 2013 Oct; 21(10):1862-75. PubMed ID: 23799534
[TBL] [Abstract][Full Text] [Related]
15. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
[TBL] [Abstract][Full Text] [Related]
16. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
17. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.
Reiner A; Del Mar N; Deng YP; Meade CA; Sun Z; Goldowitz D
J Comp Neurol; 2007 Dec; 505(6):603-29. PubMed ID: 17948889
[TBL] [Abstract][Full Text] [Related]
18. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates.
Palfi S; Brouillet E; Jarraya B; Bloch J; Jan C; Shin M; Condé F; Li XJ; Aebischer P; Hantraye P; Déglon N
Mol Ther; 2007 Aug; 15(8):1444-51. PubMed ID: 17505477
[TBL] [Abstract][Full Text] [Related]
19. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
[TBL] [Abstract][Full Text] [Related]
20. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.
Chang DT; Rintoul GL; Pandipati S; Reynolds IJ
Neurobiol Dis; 2006 May; 22(2):388-400. PubMed ID: 16473015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
